Maravai LifeSciences Holdings Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 01:30PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

I think we're ready to go. Good morning, everybody. I'm Luke Sergott from Barclays. I cover life science tools and diagnostics. It's my pleasure to have Kevin Herde from Maravai. And we're going to pretty much start on the macro here, but then we can get into some of the core business and some of the other drivers.

Questions and Answers:

Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

So with that, just give us an update on -- as we go from Ukraine, Russia, limited exposure, obviously, but I've been asking everybody if they're seeing anything from weakness in demand trends or anything else overall spilling over.

Kevin M. Herde - Maravai LifeSciences Holdings, Inc. - Executive VP & CFO

Yes. Great. Well, first of all, thanks, Luke, for having us here. It's nice to be out of the office and see all of you in person.

Specifically with regards to that region, yes, very limited exposure, no
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot